Definitive Contract 75N93023C00049
Award Date
9/15/23
Potential Completion Date
9/14/26
Potential Value
$1.5M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Qoolabs Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
22
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $300,000 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qoolabs Inc., a small disadvantaged business located in Carlsbad, California. The contract is for research and development under the Small Business Innovation Research (SBIR) program, with a period of performance through September 2025. Qoolabs is developing medical technologies related to infectious diseases, immunology,...
This federal contract award is for SBIR Phase II research and development work by Qoolabs Inc., a self-certified small disadvantaged business. The $749,999 cost-plus-fixed-fee contract was awarded on September 5, 2017 by the Department of Health and Human Services Centers for Disease Control and Prevention. The work is being performed in Atlanta, Georgia and involves the development of medical technologies related to infectious diseases, immunology, and cancer detection. This includes research...
This definitive contract from the Department of Health and Human Services' National Institutes of Health and National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) is valued at $600,000 to Qoolabs Inc. for monoclonal antibodies research aligned with SBIR Topic 107. The solicitation sought Small Business Innovation Research (SBIR) proposals across technical topics within NIH Institutes and CDC Centers to develop medical technologies, diagnostics, vaccines, cell therapies and...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Qoolabs Inc., a self-certified small disadvantaged and woman-owned business. The $150,000 contract is for critical functions, with a period of performance ending on March 20, 2017. Qoolabs Inc. is a biotech company that has received over $4 million in prime federal contracts from the Department of Health and Human Services (HHS), including the National Institutes of Health (NIH),...
This $600,000 firm fixed price definitive contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of Carlsbad, California under Solicitation Number NIH-CDC-SBIR-2023 in response to Topic 118. The contractor will conduct research and development over a two year period to produce reagents for immunologic analysis of non-mammalian and underrepresented mammalian disease models, in support of the NIH and CDC's missions. This...
This is a small business set-aside contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qoolabs Inc., a woman-owned small disadvantaged business in California. The $300,000 firm-fixed-price contract is for the development of affinity reagents for the immune system of guinea pigs. Qoolabs Inc. has previously received over $4 million in prime federal contracts from HHS agencies like NIAID and NCI for research and...
This is a $1,500,000.00 Firm Fixed Price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Qoolabs Inc., a woman-owned small disadvantaged business located in Carlsbad, California. The contract is for the production of affinity reagents for the immune system of guinea pigs, including interleukins IL1B, IL2, IL4, IL6, IL8, IL10, IL12, and IL13. There was no set-aside used for this award. Qoolabs Inc. has extensive...
This $300,000 firm fixed price contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of San Diego, California. The contract is for the development of point-of-care hepatitis C virus core antigen detection and was awarded under the Small Business Innovation Research program's solicitation PHS-2021-1. This total small business set-aside opportunity sought proposals for innovative...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Qoolabs Inc., a self-certified small disadvantaged business, for the development of affinity reagents for the immune system of guinea pigs. The $300,000 firm-fixed-price contract was awarded under the SBIR program and has a completion date of June 30, 2021. Qoolabs Inc. is a corporate entity that has received over $4 million in prime...
Qoolabs Inc. has been awarded a $400,000 firm fixed price contract by the Department of Health and Human Services National Institutes of Health National Cancer Institute to develop an at-home rapid test for hepatitis C virus detection. This contract was awarded under the Small Business Innovation Research Program Phase I action, which is set aside for small businesses. Work will be conducted by Qoolabs in San Diego, California through September 2023. The contract responds to a 2020...